Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patients
Riichiro Sugiura(Tohoku University), Kenshi Yamasaki(Tohoku University), Toshiya Takahashi(Tohoku University), Ryoko Shimada‐Omori(Tohoku University), Kenichiro Tsuchiyama(Tohoku University), Emi Yamazaki(Tohoku University), Setsuya Aiba(Tohoku University), H. Terui(Tohoku University)
Cited by 11
Related Papers
Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells
|Infection and Immunity|2005|361
Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34
|British Journal of Dermatology|1992|235
Activation of Epidermal Toll-Like Receptor 2 Enhances Tight Junction Function: Implications for Atopic Dermatitis and Skin Barrier Repair
|Journal of Investigative Dermatology|2012|171
Notch signaling: Its role in epidermal homeostasis and in the pathogenesis of skin diseases
|Journal of Dermatological Science|2007|163